Wells Fargo & Company Gilead Sciences, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 7,192,468 shares of GILD stock, worth $667 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

7,192,468

Previous 7,308,145 1.58%

Holding current value

$667 Million

Previous $501 Million 20.24%

% of portfolio

0.14%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $7.7 Million - $9.72 Million	-115,677 Reduced 1.58%	7,192,468 $603 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $15.2 Million - $17.6 Million	240,922 Added 3.41%	7,308,145 $501 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $3.96 Million - $4.83 Million	-55,319 Reduced 0.78%	7,067,223 $518 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $6.54 Million - $7.42 Million	89,291 Added 1.27%	7,122,542 $577 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $14.3 Million - $15.6 Million	-193,608 Reduced 2.68%	7,033,251 $527 Million
Q2 2023 Aug 15, 2023	SELL	$76.01 - $86.7 $28.5 Million - $32.5 Million	-374,655 Reduced 4.93%	7,226,859 $557 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $45.6 Million - $52 Million	-590,186 Reduced 7.2%	7,601,514 $631 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $21 Million - $30.2 Million	-337,231 Reduced 3.95%	8,191,700 $703 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $452,980 - $517,420	-7,608 Reduced 0.09%	8,528,931 $526 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $10.9 Million - $12.3 Million	-188,780 Reduced 2.16%	8,536,539 $528 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $80.4 Million - $101 Million	1,387,944 Added 18.92%	8,725,319 $519 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $120 Million - $137 Million	-1,855,401 Reduced 20.18%	7,337,375 $533 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $9.59 Million - $10.3 Million	-141,647 Reduced 1.52%	9,192,776 $642 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $15.3 Million - $16.7 Million	241,028 Added 2.65%	9,334,423 $643 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $16.8 Million - $19.2 Million	-279,783 Reduced 2.98%	9,093,395 $588 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $40.8 Million - $46.5 Million	720,822 Added 8.33%	9,373,178 $546 Million
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $104 Million - $130 Million	1,670,049 Added 23.92%	8,652,356 $547 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $175 Million - $203 Million	-2,419,144 Reduced 25.73%	6,982,307 $537 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $589 Million - $754 Million	9,401,451 New	9,401,451 $703 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Gilead Sciences, Inc. Transaction History